vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Bloomin' Brands, Inc. (BLMN). Click either name above to swap in a different company.
Bloomin' Brands, Inc. is the larger business by last-quarter revenue ($1.1B vs $950.5M, roughly 1.1× Astrana Health, Inc.). Bloomin' Brands, Inc. runs the higher net margin — 5.4% vs 0.7%, a 4.7% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 1.0%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 3.0%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Bloomin' Brands, Inc. is a restaurant holding company that owns several American casual dining restaurant chains. The company was established in 1988 in Tampa, Florida, where it is headquartered.
ASTH vs BLMN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.1B |
| Net Profit | $6.6M | $57.2M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 5.6% |
| Net Margin | 0.7% | 5.4% |
| Revenue YoY | 42.9% | 1.0% |
| Net Profit YoY | 184.4% | — |
| EPS (diluted) | $0.12 | $0.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $950.5M | $975.2M | ||
| Q3 25 | $956.0M | $928.8M | ||
| Q2 25 | $654.8M | $1.0B | ||
| Q1 25 | $620.4M | $1.0B | ||
| Q4 24 | $665.2M | $972.0M | ||
| Q3 24 | $478.7M | $910.0M | ||
| Q2 24 | $486.3M | $999.4M |
| Q1 26 | — | $57.2M | ||
| Q4 25 | $6.6M | $-13.5M | ||
| Q3 25 | $373.0K | $-45.9M | ||
| Q2 25 | $9.4M | $25.4M | ||
| Q1 25 | $6.7M | $42.2M | ||
| Q4 24 | $-7.8M | $-79.5M | ||
| Q3 24 | $16.1M | $6.9M | ||
| Q2 24 | $19.2M | $28.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 70.2% | ||
| Q3 25 | — | 70.4% | ||
| Q2 25 | — | 70.2% | ||
| Q1 25 | — | 70.1% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 70.5% |
| Q1 26 | — | 5.6% | ||
| Q4 25 | 1.9% | -1.4% | ||
| Q3 25 | 2.0% | -3.9% | ||
| Q2 25 | 3.1% | 3.0% | ||
| Q1 25 | 3.3% | 5.5% | ||
| Q4 24 | 0.1% | 1.7% | ||
| Q3 24 | 5.9% | 0.9% | ||
| Q2 24 | 6.2% | 4.4% |
| Q1 26 | — | 5.4% | ||
| Q4 25 | 0.7% | -1.4% | ||
| Q3 25 | 0.0% | -4.9% | ||
| Q2 25 | 1.4% | 2.5% | ||
| Q1 25 | 1.1% | 4.0% | ||
| Q4 24 | -1.2% | -8.2% | ||
| Q3 24 | 3.4% | 0.8% | ||
| Q2 24 | 3.9% | 2.8% |
| Q1 26 | — | $0.64 | ||
| Q4 25 | $0.12 | $-0.16 | ||
| Q3 25 | $0.01 | $-0.54 | ||
| Q2 25 | $0.19 | $0.30 | ||
| Q1 25 | $0.14 | $0.50 | ||
| Q4 24 | $-0.14 | $-0.93 | ||
| Q3 24 | $0.33 | $0.08 | ||
| Q2 24 | $0.40 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $71.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $398.8M |
| Total Assets | $2.2B | $3.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $71.3M | ||
| Q4 25 | $429.5M | $59.5M | ||
| Q3 25 | $463.4M | $66.5M | ||
| Q2 25 | $342.1M | $50.3M | ||
| Q1 25 | $260.9M | $57.7M | ||
| Q4 24 | $290.8M | $70.1M | ||
| Q3 24 | $350.3M | $83.6M | ||
| Q2 24 | $327.7M | $117.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $787.4M | ||
| Q3 25 | — | $962.2M | ||
| Q2 25 | — | $917.1M | ||
| Q1 25 | — | $917.6M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.0B |
| Q1 26 | — | $398.8M | ||
| Q4 25 | $779.3M | $333.6M | ||
| Q3 25 | $775.5M | $344.1M | ||
| Q2 25 | $765.5M | $397.2M | ||
| Q1 25 | $745.4M | $380.6M | ||
| Q4 24 | $712.7M | $135.5M | ||
| Q3 24 | $704.6M | $242.1M | ||
| Q2 24 | $678.9M | $286.8M |
| Q1 26 | — | $3.1B | ||
| Q4 25 | $2.2B | $3.2B | ||
| Q3 25 | $2.2B | $3.3B | ||
| Q2 25 | $1.4B | $3.3B | ||
| Q1 25 | $1.3B | $3.3B | ||
| Q4 24 | $1.4B | $3.4B | ||
| Q3 24 | $1.3B | $3.4B | ||
| Q2 24 | $1.3B | $3.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.36× | ||
| Q3 25 | — | 2.80× | ||
| Q2 25 | — | 2.31× | ||
| Q1 25 | — | 2.41× | ||
| Q4 24 | — | 7.58× | ||
| Q3 24 | — | 4.51× | ||
| Q2 24 | — | 3.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $119.1M | ||
| Q3 25 | $10.0M | $34.4M | ||
| Q2 25 | $90.9M | $49.7M | ||
| Q1 25 | $16.6M | $73.5M | ||
| Q4 24 | $-10.9M | $119.8M | ||
| Q3 24 | $34.0M | $-7.8M | ||
| Q2 24 | $23.2M | $42.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $63.7M | ||
| Q3 25 | $7.4M | $-5.7M | ||
| Q2 25 | $89.5M | $11.1M | ||
| Q1 25 | $13.6M | $27.7M | ||
| Q4 24 | $-13.5M | $66.7M | ||
| Q3 24 | $31.7M | $-67.3M | ||
| Q2 24 | $20.4M | $-12.1M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 6.5% | ||
| Q3 25 | 0.8% | -0.6% | ||
| Q2 25 | 13.7% | 1.1% | ||
| Q1 25 | 2.2% | 2.6% | ||
| Q4 24 | -2.0% | 6.9% | ||
| Q3 24 | 6.6% | -7.4% | ||
| Q2 24 | 4.2% | -1.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 5.7% | ||
| Q3 25 | 0.3% | 4.3% | ||
| Q2 25 | 0.2% | 3.8% | ||
| Q1 25 | 0.5% | 4.4% | ||
| Q4 24 | 0.4% | 5.5% | ||
| Q3 24 | 0.5% | 6.5% | ||
| Q2 24 | 0.6% | 5.5% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 1.95× | ||
| Q1 25 | 2.48× | 1.74× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | -1.13× | ||
| Q2 24 | 1.21× | 1.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BLMN
| Restaurant sales | $1.0B | 97% |
| Franchise and other revenues | $10.3M | 1% |
| Franchise revenues (1) | $7.6M | 1% |
